NRAS and neoplasm: Molecularly, all tumor models exhibit common driver mutations in CTNNB1 and AXIN1, with TLCT models showing the characteristic TERT mutation, and some models progression-associated alterations in the NFE2L2 and NRAS genes (Fig. 1b).